Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · IEX Real-Time Price · USD
6.79
-0.06 (-0.88%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Verrica Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for VRCA stock have an average target of 11.25, with a low estimate of 8.00 and a high estimate of 14. The average target predicts an increase of 65.68% from the current stock price of 6.79.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 1, 2024.
Analyst Ratings
The average analyst rating for VRCA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +17.82% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +91.46% | Mar 1, 2024 |
| Jefferies | Jefferies | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +47.28% | Dec 15, 2023 |
| Needham | Needham | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +17.82% | Nov 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +76.73% | Oct 12, 2023 |
Financial Forecast
Revenue This Year
24.48M
from 5.12M
Increased by 377.73%
Revenue Next Year
68.97M
from 24.48M
Increased by 181.73%
EPS This Year
-1.49
from -1.48
EPS Next Year
-0.87
from -1.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.0M | 84.2M | 199.5M | 367.5M | 451.5M |
| Avg | 24.5M | 69.0M | 128.3M | 247.7M | 316.8M |
| Low | 19.6M | 51.3M | 85.7M | 127.1M | 172.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 485.9% | 243.9% | 189.3% | 186.4% | 82.3% |
| Avg | 377.7% | 181.7% | 86.1% | 93.1% | 27.9% |
| Low | 282.5% | 109.4% | 24.2% | -0.9% | -30.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.91 | -0.27 | 0.24 | 4.41 | 4.41 |
| Avg | -1.49 | -0.87 | -0.30 | 1.48 | 1.98 |
| Low | -1.85 | -1.54 | -1.03 | -0.28 | 0.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 198.7% |
| Avg | - | - | - | - | 34.2% |
| Low | - | - | - | - | -74.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.